Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1

Journal of Virology

Volumn 81, Issue 23, 2007, Pages 13075-13081

  Winter, Heather Y ^a   Dayaram, Tajhal ^a   Marriott, Susan J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR ELK 1;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IN VIVO STUDY; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; SERUM RESPONSIVE ELEMENT; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE;

BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION REGULATION, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, MESSENGER; RNA, VIRAL; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 36348956803     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00968-07     Document Type: Article

References (34)

1. Barnhart, M. K., L. C. Connor, and S. J. Marriott. 1997. Function of the human T-cell leukemia-virus type 1 21-base-pair repeats in basal transcription. J. Virol. 71:337-344.
2. Bosselut, R., J. Duvall, A. Gegonne, M. Bailly, A. Hemar, J. N. Brady, and J. Ghysdael. 1990. The product of the c-ets-1 protooncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T-cell leukemia virus, HTLV-1. EMBO J. 9:3137-3144.
3. Bosselut, R., F. Lim, P.-C. Romond, J. Frampton, J. N. Brady, and J. Ghysdael. 1992. Myb protein binds to multiple sites in the human T cell lymphotropic virus type I long terminal repeat and transactivates LTR mediated expression. Virology 186:764-769.
4. Boyd, K. E., and P. J. Farnham. 1999. Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol. Cell. Biol. 19:8393-8399.
5. Boyd, K. E., J. Wells, J. Gutman, S. M. Bartley, and P. J. Farnham. 1998. c-Myc target gene specificity is determined by a post-DNA-binding mechanism. Proc. Natl. Acad. Sci. USA 95:13887-13892.
6. Brady, J. N., K.-T. Jeang, J. Duvall, and G. Khoury. 1987. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J. Virol. 61:2175-2181.
7. Braunstein, M., A. B. Rose, S. G. Holmes, C. D. Allis, and J. R. Broach. 1993. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7:592-604.
8. Buchwalter, G., C. Gross, and B. Wasylyk. 2004. Ets ternary complex transcription factors. Gene 324:1-14.
9. Charvet, C., P. Auberger, S. Tartare-Decker, A. Bernard, and M. Deckert. 2002. Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway. J. Biol. Chem. 277:15376-15384.
10. Dasgupta, P., C. D. Reddy, P. Saikumar, and E. P. Reddy. 1992. The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type I. J. Virol. 66:270-276.
11. Dodon, M. D., A. Bernard, and L. Gazzolo. 1989. Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway. J. Virol. 63:5413-5419.
12. Fujii, M., T. Niki, T. Mori, T. Matsuda, M. Matsui, N. Nomura, and M. Seiki. 1991. HTLV-I Tax induces expression of various immediate early serum responsive genes. Oncogene 6:1023-1029.
13. Fujii, M., H. Tsuchiya, T. Chuhjo, T. Akizawa, and M. Seiki. 1992. Interaction of HTLV-I Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 6:2066-2076.
14. x of HTLV-I. EMBO J. 5:713-718.
15. Gazzolo, L., and M. DucDudon. 1987. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature 326:714-717.
16. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. DeThe. 1985. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet ii:407-409.
17. Gineitis, D., and R. Treisman. 2001. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 276:24531-24539.
18. Gitlin, S. D., R. Bosselut, A. Gegonne, J. Ghysdael, and J. N. Brady. 1991. Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I. J. Virol. 65:5513-5523.
19. Hipskind, R. A., V. N. Rao, C. G. Mueller, E. S. Reddy, and A. Nordheim. 1991. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354:531-534.
20. Lin, H. C., M. Hickey, L. Hsu, D. Medina, and A. B. Rabson. 2005. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression. Virology 339:1-11.
21. 1 to a responsive element in the viral long terminal repeat. Mol. Cell. Biol. 9:4152-4160.
22. Matthews, M.-A. H., R.-B. Markowitz, and W. S. Dynan. 1992. In vitro activation of transcription by the human T-cell leukemia virus type I Tax protein. Mol. Cell. Biol. 12:1986-1996.
23. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i: 1031-1032.
24. Paskalis, H., B. K. Felber, and G. N. Pavlakis. 1986. cis-acting sequences responsible for the transcriptional activation of human T cell leukemia virus I constitute a conditional enhancer. Proc. Natl. Acad. Sci. USA 83:6558-6563.
25. Rao, V. N., K. Huebner, M. Isobe, A. ar-Rushdi, C. M. Croce, and E. S. Reddy. 1989. elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science 244:66-70.
26. Shore, P., A. J. Whitmarsh, R. Bhaskaran, R. J. Davis, J. P. Waltho, and A. D. Sharrocks. 1996. Determinants of DNA-binding specificity of ETS-domain transcription factors. Mol. Cell. Biol. 16:3338-3349.
27. Shuh, M., and D. Derse. 2000. Ternary complex factors and cofactors are essential for human T-cell leukemia virus type 1 Tax transactivation of the serum response element. J. Virol. 74:11394-11397.
28. Shuh, M., S. A. Hill, and D. Derse. 1999. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses. Virology 262:442-451.
29. Treisman, R., R. Marais, and J. Wynne. 1992. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J. 11:4631-4640.
30. Wycuff, D. R., M. D. Goff, and S. J. Marriott. 2001. Identification of an Initiator-like element within the HTLV-I promoter. Virology 280:72-79.
31. Wycuff, D. R., H. L. Yanites, and S. J. Marriott. 2004. Identification of a functional serum response element in the HTLV-I LTR. Virology 324:540-553.
32. Yanites, H. L., K. K. Woodard, and S. J. Marriott. 2003. Modular control of HTLV-I transcription: a story of cooperation and competition. Curr. Top. Virol. 3:109-117.
33. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its importance in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.
34. Zhao, L. J., and C. Z. Giam. 1992. Human T-cell lymphotropic virus type I (HTLV-1) transcriptional activator, Tax, enhances CREB binding to HTLV-1 21 base pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA 89:7070-7074.